STARTUP PROFILE

Fourier Intelligence

Updated: 07/2021

Fourier Intelligence

China / Shanghai , China

Website

Series C 07/2021

Pitch

The first Chinese rehabilitation robotics company to have its robots used for clinical and research purposes in major rehabilitation hospitals and institutions worldwide.

Why

A shortage of physiotherapists

China needs another 300,000 therapists to adequately meet the needs of rehab patients.

Large price tags

High price tags have prevented the widespread use of rehab robots.

High R&D costs

Many robotics labs have to buy expensive equipment, costing $100,000–150,000, from established suppliers.

Market

$2.6bn

Projected value of the global rehab robots market by 2026, increasing from $529m in 2018 at a CAGR of 22%: Fortune Business Insights

The rest of the content is only available if you are logged in.

Don't have a CompassList Account? Register for free

RELATED INSIGHTS

Interviews

Fourier Intelligence: Quality rehabilitation robots at affordable prices

Medtech

The Big Picture

China’s medical exoskeleton startups take on a promising but challenging market

RECOMMENDED

Indonesia Agritech Report 2020: Startups, Investors and Outlook

Download

Interviews

Fourier Intelligence: Quality rehabilitation robots at affordable prices

The startup has also launched an open-source platform to boost rehabilitation robotics and exoskeleton R&D and collaboration

Medtech | Artificial Intelligence | Robotics

The Big Picture

China’s medical exoskeleton startups take on a promising but challenging market

It was not until 2018 that the first China-made lower limb exoskeleton got regulatory clearance at home, around the same time the first Chinese rehabilitation robot got US FDA approval

Medtech | Exoskeleton | Robotics